Frontiers in Endocrinology (Jun 2024)

Microbiological profile of diabetic foot infections in China and worldwide: a 20-year systematic review

  • Yu-dun Qu,
  • Shuan-ji Ou,
  • Wei Zhang,
  • Jia-xuan Li,
  • Chang-liang Xia,
  • Yang Yang,
  • Jia-bao Liu,
  • Yun-fei Ma,
  • Nan Jiang,
  • Ye-yang Wang,
  • Bo Chen,
  • Bin Yu,
  • Yong Qi,
  • Chang-peng Xu

DOI
https://doi.org/10.3389/fendo.2024.1368046
Journal volume & issue
Vol. 15

Abstract

Read online

IntroductionPathogens causing diabetic foot infections (DFIs) vary by region globally; however, knowledge of the causative organism is essential for effective empirical treatment. We aimed to determine the incidence and antibiotic susceptibility of DFI pathogens worldwide, focusing on Asia and China.MethodsThrough a comprehensive literature search, we identified published studies on organisms isolated from DFI wounds from January 2000 to December 2020.ResultsBased on our inclusion criteria, we analyzed 245 studies that cumulatively reported 38,744 patients and 41,427 isolated microorganisms. DFI pathogens varied according to time and region. Over time, the incidence of Gram-positive and Gram-negative aerobic bacteria have decreased and increased, respectively. America and Asia have the highest (62.74%) and lowest (44.82%) incidence of Gram-negative bacteria, respectively. Africa has the highest incidence (26.90%) of methicillin-resistant Staphylococcus aureus. Asia has the highest incidence (49.36%) of Gram-negative aerobic bacteria with species infection rates as follows: Escherichia coli, 10.77%; Enterobacter spp., 3.95%; and Pseudomonas aeruginosa, 11.08%, with higher local rates in China and Southeast Asia. Linezolid, vancomycin, and teicoplanin were the most active agents against Gram-positive aerobes, while imipenem and cefoperazone-sulbactam were the most active agents against Gram-negative aerobes.DiscussionThis systematic review showed that over 20 years, the pathogens causing DFIs varied considerably over time and region. This data may inform local clinical guidelines on empirical antibiotic therapy for DFI in China and globally. Regular large-scale epidemiological studies are necessary to identify trends in DFI pathogenic bacteria.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42023447645.

Keywords